Patents by Inventor Derek Piper

Derek Piper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260176270
    Abstract: Disclosed herein are compounds according to Formula I. (I). Compounds according to Formula I inhibit PKMYT1 and are useful for the treatment of cancer and other disease. The present invention also provides methods for making compounds as mentioned above, and compositions which contain these compounds.
    Type: Application
    Filed: November 22, 2023
    Publication date: June 25, 2026
    Inventors: Wei XU, Paige Erin MAHANEY, Benjamin R. BOSWELL, David J. COLE, Paul GILLESPIE, Faming JIANG, Ryan KELLEY, Rachael LANSDOWN, Xiaodong LIN, Sunghoon MA, Jack MAUNG, Danny NG, Jian Mehr-Dean PAYANDEH, Derek PIPER, Sandeep N. RAIKAR, Lynne Bannen, Alice C. RICO, Justin SALVANT, Andre H. ST. AMANT, Yong WANG, Zhensheng ZHAO, Guosheng WU, Beichen ZHANG
  • Publication number: 20060270718
    Abstract: Heterocyclic arylsulfonamidobenzylic compounds are provided which are useful in treating lipid disorders, metabolic disorders and cell-proliferative diseases.
    Type: Application
    Filed: August 8, 2006
    Publication date: November 30, 2006
    Inventors: Xian Jiao, Frank Kayser, David Kopecky, Sharon McKendry, Derek Piper, Andrew Shiau
  • Publication number: 20060122239
    Abstract: Arylsulfonamidobenzyl alcohols, amines and sulfonamides are provided which are useful in treating lipid disorders, metabolic diseases and cell-proliferative diseases.
    Type: Application
    Filed: January 17, 2006
    Publication date: June 8, 2006
    Inventors: Xian Jiao, Frank Kayser, Sharon McKendry, Derek Piper, Andrew Shiau
  • Publication number: 20050152896
    Abstract: The present invention provides antibodies that immunospecifically bind to a galanin peptide and compositions comprising said antibodies. The present invention also provides methods for preventing, treating, managing, and/or ameliorating hyperproliferative disorders or a symptom thereof comprising administering to a subject in need thereof one or more antibodies that immunospecifically bind to a galanin peptide. The invention also encompasses methods and compositions for diagnosing, monitoring, and prognosing hyperproliferative disorders. The present invention further relates to articles of manufacture and kits comprising antibodies that immunospecifically bind to a galanin peptide.
    Type: Application
    Filed: December 10, 2004
    Publication date: July 14, 2005
    Applicant: Amgen Inc.
    Inventors: Wade Aaron, Richard Austin, Cynthia Hart, Timothy Hoey, Paul Kassner, Derek Piper, Anthony Slavin